GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.70 $7.70 Friday, 19th Apr 2024 FATE stock ended at $4.79. This is 4.96% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 8.84% from a day low at $4.70 to a day high of $5.11.
90 days $4.40 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2020-10-26 $47.66 $48.75 $45.71 $46.90 457 366
2020-10-23 $47.97 $48.60 $47.06 $48.36 319 654
2020-10-22 $44.85 $48.28 $44.85 $47.71 750 390
2020-10-21 $47.98 $48.79 $43.02 $44.46 1 017 364
2020-10-20 $47.88 $48.98 $47.08 $48.19 1 349 519
2020-10-19 $49.12 $49.66 $47.20 $47.52 1 621 766
2020-10-16 $48.24 $51.10 $48.24 $48.64 1 608 072
2020-10-15 $47.59 $48.56 $46.60 $48.10 1 048 723
2020-10-14 $48.67 $49.59 $46.87 $46.96 982 686
2020-10-13 $48.61 $49.68 $48.00 $49.04 625 919
2020-10-12 $48.73 $49.13 $47.34 $48.75 467 609
2020-10-09 $45.09 $48.10 $44.64 $48.01 745 900
2020-10-08 $44.72 $45.30 $44.19 $44.98 525 951
2020-10-07 $42.31 $44.35 $41.76 $44.04 771 699
2020-10-06 $41.80 $42.55 $41.38 $41.56 858 746
2020-10-05 $38.39 $42.00 $38.09 $41.89 1 104 619
2020-10-02 $39.16 $40.08 $38.02 $38.09 1 190 963
2020-10-01 $40.41 $42.22 $39.65 $40.61 1 273 846
2020-09-30 $39.40 $41.18 $39.22 $39.97 881 625
2020-09-29 $40.25 $41.36 $39.09 $39.40 1 336 205
2020-09-28 $38.23 $40.52 $37.89 $40.50 961 609
2020-09-25 $35.80 $37.97 $35.80 $37.80 629 441
2020-09-24 $36.39 $37.19 $35.47 $35.99 717 055
2020-09-23 $36.88 $38.38 $36.20 $36.47 986 215
2020-09-22 $36.98 $37.26 $35.40 $37.09 1 338 373
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT